Anna Kosova

Dr. Anna Kosova


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2024 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
RSRoman Shaikenov
Roman Shaikenov
VKVladislava Klimshina
Vladislava Klimshina
YGYuliya Generalova
Yuliya Generalova
PSPolina Serbun
Polina Serbun
AKAnna Kosova
Anna Kosova
Petr P. SnetkovPetr P. Snetkov
Petr P. Snetkov
The rise in antibiotic-resistant bacterial infections is a major global health concern. The search for natural compounds that inhibit the growth of pathogens is becoming urgent. One such compound is mangiferin, a non-toxic polyphenolic compound derived mainly from Mangifera indica. In addition to antibacterial properties, it exhibits anticancer, antioxidant, immunomodulatory, analgesic and other activities. However, the clinical application of mangiferin is limited by poor solubility and bioavailability. This study describes mangiferin-loaded electrospun nanofibers based on high-molecular-weight hyaluronic acid. The nanofibers improve mangiferin delivery and possess favorable morphological characteristics and drug release kinetics, making them promising candidates for effective antibacterial dressings. This study found that an increase in the mangiferin content of the fibers led to an increase in the average diameter of the fibers. It was also found that nanofibers with different mangiferin content have similar release kinetics with an anomalous non-Fickian transport pattern: most of the mangiferin is released within 10–15 min.

8 July 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
DIDmitri O. Ivanov
Dmitri O. Ivanov
RSRoman Shaikenov
Roman Shaikenov
SMSvetlana Morozkina
Svetlana Morozkina
Petr P. SnetkovPetr P. Snetkov
Petr P. Snetkov
RNRuslan Abdullaevich Nasyrov
Ruslan Abdullaevich Nasyrov
IKIgor Kvetnoy
Igor Kvetnoy
The review evaluates current clinical and epidemiological evidence regarding the use of plant-derived compounds in pediatric practice. Data from randomized controlled trials indicate symptomatic efficacy of selected agents—particularly in acute respiratory infections—alongside generally favorable safety profiles when standardized preparations are used. Emerging research also explores applications in neurodevelopmental disorders, gastrointestinal conditions, and dermatology, and as supportive therapy in pediatric oncology. However, variability in product quality, limited pediatric-specific trials, potential toxicity, and regulatory inconsistencies remain significant challenges. The integration of phytotherapy into pediatric care therefore requires rigorous study design, careful safety monitoring, and clear quality standards to ensure an evidence-based risk–benefit balance.

Verified
Journal Article
Open access
PDF file
PSPolina Serbun
Polina Serbun
RSRoman Shaikenov
Roman Shaikenov
Petr P. SnetkovPetr P. Snetkov
Petr P. Snetkov
AKAnna Kosova
Anna Kosova
MBMikhail Budanov
Mikhail Budanov
SMSvetlana Morozkina
Svetlana Morozkina
This review presents an interdisciplinary analysis of small-molecule-encapsulated smart polymer materials for tissue engineering. Key design principles, including biocompatibility, degradation, and mechanical properties, are discussed, as well as the fabrication methods (hydrogels, electrospinning, porous matrices, and 3D printing). The following strategies for the immobilization of therapeutic agents are compared: physical retention, affinity binding, secondary carriers, post-loading, and covalent conjugation. Four main release mechanisms are analyzed, as well as material characterization, and the release kinetics are discussed. Preclinical in vitro and in vivo studies, including the disease models and the mechanistic validation, are presented, as well as a critical review of the clinical trials, identifying the following main reasons for failure: the lack of the superiority over the standard therapy, the complexity of the manufacturing, and the scale-up. The role of artificial intelligence in the acceleration of property prediction and system optimization is highlighted. Limitations are outlined and it is shown that successful translation requires a minimum level of sufficient complexity and a reproducible relationship between the structure, release, and the therapeutic window.

4 September 2026 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
AKAnna Kosova
Anna Kosova
MNMaria Naumenko
Maria Naumenko
SZSergei G. Zhuravskii
Sergei G. Zhuravskii
GYGalina Y. Yukina
Galina Y. Yukina
ESElena G. Sukhorukova
Elena G. Sukhorukova
SMSvetlana Morozkina
Svetlana Morozkina
Regenerative medicine in otorhinolaryngology faces substantial challenges in restoring of middle ear structures, particularly the eardrum, because the traditional methods have the limitations. In t...

22 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Ekaterina S. MironovaEkaterina S. Mironova
Ekaterina S. Mironova
SPStanislav Poyarkov
Stanislav Poyarkov
AKAnna Kosova
Anna Kosova
VAViktor Antonov
Viktor Antonov
SBSofya Markovna Balazovskaia
Sofya Markovna Balazovskaia
Gianluigi MazzoccoliGianluigi Mazzoccoli
Gianluigi Mazzoccoli
Maintaining healthy longevity requires slowing down age-related changes and supporting the body's ability to recover function after stress. With age, the adaptive response becomes increasingly compromised: inflammation and metabolic mobilization persist, the reserve decreases, and allostatic load accumulates. This article reviews data on age-related changes through the concept of the redox code — the spatiotemporal organization of electron transfer, reduction fluxes, and reversible protein modifications. This approach enables us to correlate molecular mechanisms of aging with the disruption of effective feedback loops, mitochondrial maintenance, and cellular turnover. Based on advances in redox biology and the results of studying precursor drugs, we proposed a concept of the pharmacological modulation of the redox code in the context of adaptive response development — signal perception, matching needs with resources, and timely restoration of regulatory circuits. The proposed approach has been shown to complement risk mitigation, physical adaptation, interference with cellular renewal, and epigenetic reprogramming. Organ-specific ageotypes and the circadian phases determine the individual context of modulation. This approach distinguishes the reductive capacity as an independent level of healthy longevity pharmacology. Its practical results include the completion of adaptation, decreased residual chronic stress, and preserving readiness for subsequent impacts.

15 July 2026 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
AKAnna Kosova
Anna Kosova
Petr P. SnetkovPetr P. Snetkov
Petr P. Snetkov
SMSvetlana Morozkina
Svetlana Morozkina
Background. Radionuclide therapy and molecular imaging are promising areas of nuclear medicine based on the selective accumulation of radiopharmaceuticals in pathological foci. Hyaluronic acid (HA) is of particular interest as a biocompatible platform for targeted radionuclide delivery due to its binding to CD44 (cluster of differentiation 44), RHAMM (receptor for hyaluronan-mediated motility), and TRL (Toll-like receptors) overexpressed in tumor, inflammatory, and degenerative diseases. Aim. Analysis of modern approaches for the obtaining of radiolabeled HA, radionuclides used, imaging methods and prospects for the use of hyaluronic-based matrices in the diagnosis and theranostics of diseases. Materials and methods. The analysis of hyaluronic-based matrices data published mainly after 2020 and presented in the international scientific databases PubMed, Google Scholar, Scopus and other peer-reviewed sources is carried out. Additionally, early fundamental research on the metabolism and radiotherapy of HA is reviewed. Results. The main methods for the obtaining of radiolabeled HA, including direct and chelator-mediated labeling, as well as the most commonly used radionuclides for diagnosis and therapy, including technetium-99m, gallium-68, iodine-125, iodine-131, lutetium-177 and yttrium-90, are considered. It has been shown that due to its high biocompatibility, the presence of functional groups for modification, and the ability to selectively bind to cellular receptors, HA provides targeted accumulation of radiopharmaceuticals in tumor, inflammatory, and fibrous tissues. Special attention is paid to the methods of single-photon emission computed tomography and positron emission tomography with computed tomography, which make it possible to visualize the bio-distribution of radiolabeled hyaluronic matrices in vivo. Examples of radiopharmaceuticals based on HA containing additional therapeutic agents, including curcumin, for the realization of a synergistic theranostic effect are considered. Conclusion. HA is a promising platform for the creation of radiopharmaceuticals due to its high biocompatibility, the possibility of chemical modification and selective interaction with receptors of pathologically altered tissues. The use of radiolabeled hyaluronic matrices opens up broad prospects for the development of personalized diagnostics, molecular imaging, and targeted radionuclide therapy.